Showing results (2031-2040 of 3,730) with videos related to

Sort By:
Pageof 373
Genes and Immunity|March 15, 2018
Genome-wide association study (GWAS) of human host factors influencing viral severity of herpes simplex virus type 2 (HSV-2)Sarah E Kleinstein, Patrick R Shea, Andrew S Allen, et al.
Journal of Thoracic Imaging|April 7, 2020
Multimodality Assessment of Thoracic Aortic Dimensions: Comparison of Computed Tomography Angiography, Magnetic Resonance Imaging, and Echocardiography MeasurementsCaio Frazao, Anahita Tavoosi, Bernd J Wintersperger, et al.
Cancer Genetics and Cytogenetics|June 1, 1997
Acquired monosomy 7 in donor cells in a patient treated for acute lymphoblastic leukemia with bone marrow transplantationS Shekhter-Levin, E J Bloom, S H Swerdlow, et al.
Prenatal Diagnosis|November 1, 1985
A survey of diagnostic amniocenteses in Oxford from 1974-1981E Terzian, J Boreham, H S Cuckle, et al.
Trials|October 8, 2013
Standard versus accelerated initiation of renal replacement therapy in acute kidney injury (STARRT-AKI): study protocol for a randomized controlled trialOrla M Smith, Ron Wald, Neill K J Adhikari, et al.
BMJ (Clinical Research Ed.)|January 11, 2012
The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysisZiv Harel, Cameron Gilbert, Ron Wald, et al.
Health Care Management Science|January 4, 2021
Stochastic programming for outpatient scheduling with flexible inpatient exam accommodationYifei Sun, Usha Nandini Raghavan, Vikrant Vaze, et al.
AJNR. American Journal of Neuroradiology|July 24, 2021
Calcified Pseudoneoplasm of the NeuraxisJ C Benson, J Trejo-Lopez, J Boland-Froemming, et al.
Plos One|August 8, 2019
Reconfigurable MRI coil technology can substantially reduce RF heating of deep brain stimulation implants: First in-vitro study of RF heating reduction in bilateral DBS leads at 1.5 TLaleh Golestanirad, Ehsan Kazemivalipour, Boris Keil, et al.
Clinical and Vaccine Immunology : CVI|March 21, 2008
Phase I dose-escalation study of a monovalent heat shock protein 70-herpes simplex virus type 2 (HSV-2) peptide-based vaccine designed to prime or boost CD8 T-cell responses in HSV-naïve and HSV-2-infected subjectsDavid M Koelle, Amalia Magaret, Christopher L McClurkan, et al.
Pageof 373